425
Participants
Start Date
October 31, 2007
Primary Completion Date
May 31, 2008
Study Completion Date
May 31, 2008
Atorvastatin
Prescription of 10/20/40mg dose atorvastatin based on the personal risk factor that is defined in the NCEP ATP III guideline in a single patient group
Pfizer Investigational Site, Daegu
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Busan
Pfizer Investigational Site, Busan
Pfizer Investigational Site, Daegu
Pfizer Investigational Site, Daejeon
Pfizer Investigational Site, Gwangju
Pfizer Investigational Site, Gwangju
Pfizer Investigational Site, Gyeonggi-do
Pfizer Investigational Site, Gyeonggi-do
Pfizer Investigational Site, Incheon
Pfizer Investigational Site, Kyunggi-do
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Seoul
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY